CD4 and neoplasm: As the anti-CD4 antibody depletes CD4-expressing cytokine sinks3,15, adequate treatment after preconditioning in ACT has the potential to induce synergistic anti-tumor responses by enhancing the activity of ex-T cells and endogenous CD8+ T cells (en-T cells; a newly repopulating subset after lymphodepletion).